The drug test is coming! Multiple batches of drugs recalled and sold out

On July 9, the Shandong Provincial Drug Administration, in order to strengthen drug quality supervision and ensure the safety of public drug use, conducted supervision and sampling of drug production, operation and use units in accordance with the annual sampling work plan of the Provincial Drug AdministrationAnd issued the 2020 Issue 4 drug quality sampling noticeThe notice shows that 14 varieties of 15 production enterprises (preparation units) have a total of 16 batches of drugs, which are not in accordance with the standard requirements after samplingThe combing found that the 16 batches of drugs, there are 6 batches of preparations, 10 batches of drinking tablets, involving commonly used drug compound amoline tablets, compound acetaminophen tablets and so onin accordance with the circular, the relevant drug regulatory departments have taken control measures such as seizure, seizure, suspension of sale and product recall of non-compliant products, and shall, in accordance with relevant laws and regulations, seriously investigate and punish the relevant production enterprises (preparation units) and sample dissampled units in accordance with the lawunique, in addition to Shandong, a number of provinces have also recently published a number of drug quality sampling notice, including a number of products were recalled, stop salesas on July 6, Hubei Provincial Drug Administration issued the 2nd issue of 2020 drug quality bulletinIn this drug quality sampling, it was found that 65 batches did not meet the standard requirements, including 4 preparations andraw materials, 61 kinds ofChinese medicine(drink tablets)According to the list of publicly available drugs, these non-standard drugs include vitamin zinc capsules, kidney-replenishing capsules and other 4 preparations and raw materials, as well as earthworms, chimmion, dansan, five-plus skin, hook rattan and other 61 kinds of medicinal materials (drink tablets)Involved in more than 50 production enterprisesat present, the municipal (state) market supervision authority of the drugs and related units that do not meet the standards in the announcement is investigating and dealing with them in accordance with the provisions of the Drug Administration Law of the People's Republic of China, and the results of the processing and related circumstances will be reported in a timely mannerJune Heilongjiang Provincial Drug Administration also issued this year's first issue of the drug quality sampling notice, a total of 16 batches of drugs do not meet the requirements, including common drugs It is understood that non-compliant chemical drugs, antibiotics, biochemical drugs, traditional Chinese medicine has 3 batches, do not meet the provisions of Chinese herbal medicine, Chinese medicine tablets a total of 13 batches Non-compliance items include "character" "content determination" "pharmacy impurities" and so on, The content of chinese medicine drinking tablets non-conforming to the provisions of the content sesame of the medicinal species, defective preparation process, improper storage and other cases for non-compliant drugs, The drug supervision and administration departments at all levels in Heilongjiang Province have asked the relevant enterprises and units to adopt risk control measures such as suspension of sales and use, to investigate the reasons for non-compliance and to carry out effective rectification it is worth noting that from the above-mentioned sampling of unqualified drugs can be found that Chinese medicine tablets are still the focus area in the drug sampling link Although the non-conformity ratio is still high, but in 2019 published the results of the national drug sampling of Chinese medicine tablets sampling pass rate of 91%, up 3 percentage points from 2018, under strict supervision, China's Chinese herbal medicine and drink tablets product pass rate is increasing year by year, the industry is gradually moving towards the direction of standardization Therefore, in 2020, in the context of increased drug regulation, the quality of drinking tablets should continue to improve in general, the inspection work of the various fda bureaus is slowly getting back on track Industry is expected that there will be a large wave of key supervision and inspection, targeted inspection coming, pharmaceutical companies cut mo with a lucky mentality, strengthen the quality and safety of drug production is the king of continuous operation!